UPDATE: PTC Therapeutics (PTCT) Initiated Neutral at UBS
Tweet
Share
E-mail
Get Alerts PTCT Hot Sheet
Price: $82.13 --0%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 25
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 25
Join SI Premium – FREE
(Updated - October 27, 2020 5:00 PM EDT)
UBS analyst Colin Bristow started PTC Therapeutics (NASDAQ: PTCT) at Neutral, PT $55.00
You May Also Be Interested In
- Barrington Research Starts CBIZ, Inc. (CBZ) at Outperform
- Goldman Sachs Assumes Zeta Global Holdings Corp (ZETA) at Neutral
- Canaccord Starts Elixir Energy Ltd (EXR:AU) at Spec. Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
